z-logo
Premium
Photobiomodulation in human muscle tissue: an advantage in sports performance?
Author(s) -
Ferraresi Cleber,
Huang YingYing,
Hamblin Michael R.
Publication year - 2016
Publication title -
journal of biophotonics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.877
H-Index - 66
eISSN - 1864-0648
pISSN - 1864-063X
DOI - 10.1002/jbio.201600176
Subject(s) - medicine , human muscle , athletes , muscle fatigue , muscle hypertrophy , muscle tissue , creatine kinase , randomized controlled trial , human studies , myocyte , physical therapy , physical medicine and rehabilitation , skeletal muscle , electromyography
Photobiomodulation (PBM) describes the use of red or near‐infrared (NIR) light to stimulate, heal, and regenerate damaged tissue. Both preconditioning (light delivered to muscles before exercise) and PBM applied after exercise can increase sports performance in athletes. This review covers the effects of PBM on human muscle tissue in clinical trials in volunteers related to sports performance and in athletes. The parameters used were categorized into those with positive effects or no effects on muscle performance and recovery. Randomized controlled trials and case‐control studies in both healthy trained and untrained participants, and elite athletes were retrieved from MEDLINE up to 2016. Performance metrics included fatigue, number of repetitions, torque, hypertrophy; measures of muscle damage and recovery such as creatine kinase and delayed onset muscle soreness. Searches retrieved 533 studies, of which 46 were included in the review ( n = 1045 participants). Studies used single laser probes, cluster of laser diodes, LED clusters, mixed clusters (lasers and LEDs), and flexible LED arrays. Both red, NIR, and red/NIR mixtures were used. PBM can increase muscle mass gained after training, and decrease inflammation and oxidative stress in muscle biopsies. We raise the question of whether PBM should be permitted in athletic competition by international regulatory authorities.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here